The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...

Modern medicine is continually advancing treatment options for many chronic health conditions. For type 2 diabetes and obesity, GLP-1 receptor agonists are medications that may benefit your current ...

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs. Objectives: Medication ...

Pharmaceutical companies are developing new weight-loss treatments that aim to shed the pounds while preserving muscle mass - ...

When it comes to kidney and cardiovascular outcomes, there is no significant difference between treatment with an SGLT2 inhibitor or GLP-1 receptor agonist in patients with type 2 diabetes, according ...

We interviewed a physician who provides guidance for patients with diabetes who wish to fast for religious or non-religious reasons. Fasting has been an integral part of religious practices for ...

Learning more about diabetes care — and how to go about it — can help you create a streamlined diabetes management plan and make necessary lifestyle changes. Diabetes is a chronic medical condition ...